Thomas Wirth

8.2k total citations · 1 hit paper
178 papers, 6.3k citations indexed

About

Thomas Wirth is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Thomas Wirth has authored 178 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 49 papers in Immunology and 38 papers in Molecular Biology. Recurrent topics in Thomas Wirth's work include Immunotherapy and Immune Responses (24 papers), Hip disorders and treatments (23 papers) and Immune Cell Function and Interaction (22 papers). Thomas Wirth is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), Hip disorders and treatments (23 papers) and Immune Cell Function and Interaction (22 papers). Thomas Wirth collaborates with scholars based in Germany, United States and Austria. Thomas Wirth's co-authors include David Baltimore, Louis M. Staudt, Stefan Zwilling, Florian Kühnel, Ranjan Sen, Harinder Singh, Phillip A. Sharp, Michael P. Manns, Harald König and Stefan Kubicka and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas Wirth

166 papers receiving 6.2k citations

Hit Papers

A lymphoid-specific protein binding to the octamer motif ... 1986 2026 1999 2012 1986 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Wirth Germany 44 2.5k 2.1k 1.6k 1.1k 841 178 6.3k
Shingo Fujii Japan 49 2.7k 1.1× 2.1k 1.0× 2.2k 1.3× 947 0.8× 746 0.9× 164 8.1k
Dietmar Pfeifer Germany 37 2.2k 0.9× 3.2k 1.5× 742 0.5× 733 0.7× 1.2k 1.4× 128 6.6k
Kenji Kawabata Japan 42 3.6k 1.4× 1.7k 0.8× 2.1k 1.3× 1.6k 1.4× 1.1k 1.3× 182 7.4k
Hartmut Merz Germany 26 1.3k 0.5× 1.7k 0.8× 1.0k 0.6× 556 0.5× 428 0.5× 119 4.4k
Kenzaburo Tani Japan 38 2.4k 1.0× 1.4k 0.7× 1.2k 0.7× 1.1k 1.0× 367 0.4× 225 5.4k
Robert Sackstein United States 48 2.4k 0.9× 2.7k 1.3× 1.8k 1.1× 645 0.6× 1.2k 1.4× 150 7.5k
Arinobu Tojo Japan 45 3.1k 1.2× 1.6k 0.7× 1.9k 1.2× 515 0.5× 816 1.0× 364 8.2k
Ashley R. Dunn Australia 50 3.6k 1.4× 4.9k 2.3× 2.0k 1.2× 1.1k 1.0× 519 0.6× 101 10.0k
Darren P. Baker United States 40 3.3k 1.3× 1.8k 0.8× 1.4k 0.8× 600 0.5× 247 0.3× 103 5.8k

Countries citing papers authored by Thomas Wirth

Since Specialization
Citations

This map shows the geographic impact of Thomas Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wirth more than expected).

Fields of papers citing papers by Thomas Wirth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wirth. The network helps show where Thomas Wirth may publish in the future.

Co-authorship network of co-authors of Thomas Wirth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wirth. A scholar is included among the top collaborators of Thomas Wirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wirth. Thomas Wirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mundt, Bettina, Norman Woller, Valery Volk, et al.. (2025). Oncolytic viruses expressing MATEs facilitate target-independent T-cell activation in tumors. EMBO Molecular Medicine. 17(2). 265–300.
2.
Ostroumov, Dmitrij, et al.. (2025). Sequential STING and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines. Cellular and Molecular Immunology. 22(2). 150–160. 3 indexed citations
3.
Wirth, Thomas, Marielle Martin, F. Amatore, et al.. (2024). POS0965 EXPLORING ANTIBODIES IN PSORIATIC ARTHRITIS: A NOVEL AUTOIMMUNE BIOMARKER DISCOVERED. Annals of the Rheumatic Diseases. 83. 700–700. 1 indexed citations
4.
Möhn, Nora, Lea Grote‐Levi, Tabea Seeliger, et al.. (2023). Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity. Cancer Medicine. 12(8). 9373–9383. 18 indexed citations
5.
Hecker‐Nolting, Stefanie, Leo Kager, Thomas Kühne, et al.. (2022). Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. Journal of Adolescent and Young Adult Oncology. 12(1). 76–82. 2 indexed citations
6.
Fernandez, F. F., Thomas Wirth, & O. Eberhardt. (2022). Arthroskopische Reposition der kongenitalen Hüftgelenkluxation im Säuglingsalter. Operative Orthopädie und Traumatologie. 34(4). 253–260.
7.
Wirth, Thomas. (2021). Congenital Vertical Talus. Foot and Ankle Clinics. 26(4). 903–913. 10 indexed citations
8.
Woller, Norman, Jennifer D. Brooks, Bettina Fleischmann-Mundt, et al.. (2019). Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy. Nature Communications. 10(1). 3236–3236. 52 indexed citations
9.
Ostroumov, Dmitrij, Sarah Knocke, Norman Woller, et al.. (2017). CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations. Cancer Research. 77(8). 1918–1926. 32 indexed citations
10.
Brooks, Jennifer D., Bettina Fleischmann-Mundt, Norman Woller, et al.. (2017). Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer. Cancer Research. 78(2). 475–488. 55 indexed citations
11.
Wirth, Thomas. (2016). Avulsionsverletzungen der Hüftregion des Jugendlichen. Der Orthopäde. 45(3). 213–218. 8 indexed citations
12.
Rausch, Vanessa, Li Liu, Georgios Kallifatidis, et al.. (2010). Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics. Cancer Research. 70(12). 5004–5013. 169 indexed citations
14.
Wirth, Thomas, Vladimir P. Badovinac, Lichao Zhao, Morris O. Dailey, & John T. Harty. (2009). Differentiation of Central Memory CD8 T Cells Is Independent of CD62L-Mediated Trafficking to Lymph Nodes. The Journal of Immunology. 182(10). 6195–6206. 13 indexed citations
15.
Wirth, Thomas, et al.. (2001). Prevention of venous thromboembolism after knee arthroscopy with low–molecular weight heparin (Reviparin). Arthroscopy The Journal of Arthroscopic and Related Surgery. 17(4). 393–399. 101 indexed citations
16.
Kastenbauer, Stefan, Angela Wedel, Marion Frankenberger, Thomas Wirth, & H.W.L. Ziegler-Heitbrock. (1996). Analysis of Promoter Activity by Polymerase Chain Reaction Amplification of Reporter Gene mRNA. Analytical Biochemistry. 233(1). 137–139. 7 indexed citations
17.
Wirth, Thomas, Sharon Byers, Roger W. Byard, John J. Hopwood, & Bruce K. Foster. (1994). The implantation of cartilaginous and periosteal tissue into growth plate defects. International Orthopaedics. 18(4). 220–8. 29 indexed citations
18.
Wirth, Thomas, et al.. (1992). Oct2 Transactivation from a Remote Enhancer Position Requires a B-Cell-Restricted Activity. Molecular and Cellular Biology. 12(7). 3107–3116. 58 indexed citations
19.
Scheuermann, Richard H., et al.. (1991). Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimuulated mouse splenic B-cells. Nucleic Acids Research. 19(21). 5981–5989. 12 indexed citations
20.
Herda, Christoph, Thomas Wirth, H.-D. Basler, Irmela Florin, & P. Griss. (1991). Prognose des Erfolges von Operationen and der Bandscheibe. Eine Untersuchung an Patienten mit Schmerzen nach einem lumbalen Bandscheibenvorfall. Der Schmerz. 5(3). 148–154. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026